Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Glioblastoma × Cell Count × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Magnetic Resonance Spectroscopy 14 Blood Specimen Collection 7 Temozolomide 6 Bevacizumab 5 Radiotherapy 4 Surgical Procedures, Operative 3 Radiation 3 Biopsy 3 Yoga 2 Standard of Care 2 Specimen Handling 2 Restraint, Physical 2 Radiotherapy, Intensity-Modulated 2 Radiosurgery 2 Psychosocial Intervention 2 Perfusion Magnetic Resonance Imaging 2 Palliative Care 2 Mind-Body Therapies 2 Lomustine 2 Gadolinium DTPA 2 Elasticity Imaging Techniques 2 Early Intervention, Educational 2 Drug Therapy 2 Diet Therapy 2 Dexamethasone 2 Chemotherapy, Adjuvant 2 Aminolevulinic Acid 2 tislelizumab 1 gallium Ga 68 dotatate 1 gadoteridol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07144735 2025-08-27

ABOUT

Peking University Third Hospital

Phase NA Recruiting

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡